Accuracy of Oncotype DX Test!!

Options
msShelly
msShelly Member Posts: 55
edited June 2014 in Stage I Breast Cancer

hello- another post on these boards discussed a personal case where testing different areas of the tumor (biopsy tumor and surgery tumor) yielded different Oncotype scores.

i am posting for some clarification on the issue because i am bit confused. i was told that the test takes differentiation into account and that this is not a problem with the oncotype test because literally all tumors exibit wide differentiation depending on what part of the tumor is tested. I have also heard that the test was validated in studies where they took samples from different areas of each tumor and came up with equivalent scores regardless of what part of the tumor the sample came from.

could someone with more knowledge of oncotype test please post to clarify this issue. im skipping chemo because my score is low, but i would really worry if there was not some type of control to deal with possible differentiation in the tumor. i am assuming there must be because without one, most of the scores would not be accurate. thanks!

Comments

  • NancyHB
    NancyHB Member Posts: 1,512
    edited March 2013

    MsShelly:  I am not a scientist, nor do I play one on TV.  But, I had some discordant results between my biopsy and Oncotype test, so I've been asking lots of questions and getting (what I think are) answers along the way.

    In a nutshell:  my biopsy showed Grade 2 (moderately differentiated) ER/PR+ Her2-.  I've got the path report and it's pretty straight-forward.  My Oncotype test came back at a 42, which indicates high Ki67 proliferation (my original path does not include a Ki67 test), and my tumor was detailed as barely ER+ (6.6 on a scale where 6.5 is the cut-off for negative), and PR- and Her2-.  So, am I positive, or negative?  Am I in a "good place" (1.3cm tumor, Grade 2) or in a "bad place" (high Ki67, high rate of recurrence?)

    For planning purposes (treatment...and life...) I tend to side with the Oncotype test results.

    My MO says that in general, the Oncotype test confirms what the path report details.  Path comes from a specific area of the tumor, but since the understanding is that most tumors are homogenous (they're pretty much the same through-and-through), what you're getting is a representative sample.  Oncotype grinds up the sample and then tests genetic markers - so it's like a tumor smoothie, and you might find something in that that you didn't find in the original path sample.  While I have yet to be able to find a peer-reviewed article that confirms this, what I've been told is that the huge difference between path and Oncotype often happens when there is an aggressive cancer involved.  With a 42 Oncotype score, I have an 18% recurrence rate with chemo and five years of Tamoxifen.

    But for what it's worth chemo doesn't promise non-recurrence, for someone with a score of 42 - or 10.  For you, the risks of chemo far outweigh the benefits - even if it that doesn't seem to be the case.  I mean, conventional wisdom says that if you have chemo you'll be that much safer from recurrence, right?  It can be hard to believe that forgoing chemo may actually be better for you.

    I'm hoping someone else with a wealth of knowledge comes along and has a better explanation than I do. I don't know if I've helped at all.

  • Moderators
    Moderators Member Posts: 25,912
    edited March 2013

    Hi msShelly, 

    We'd like to make a few suggestions that may help. First, you may find it helpful to read the section on our site regarding Oncotype dx testing: http://www.breastcancer.org/symptoms/testing/types/oncotype_dx

    Secondly, you may want to consider calling Genomic Health's Customer Service number [Tel: +1 (866) ONCOTYPE (866-662-6897]. Patients can call that number and speak to a live person who can give them any kind of information they want about the test, studies done on Oncotype DX, information about their specific test (if a patient has had an Oncotype ordered) and information about navigating insurance issues.

    We sincerely hope that this information can help guide you. 

    Warmly, 

    The Mods

  • lisa2012
    lisa2012 Member Posts: 652
    edited March 2013

    This happened to me too. My original path showed ER+ (about 30percent) stage 1 grade 3, node negative. K167 like 140.

    Had the oncotype. First go-around they couldn't get it from my biopsy. Sent a piece of my tiny tumor. Got a 38 on that- but their RNA test said I was ER negative. Like you, some smidge under the <6 or whatever. So was the oncotype valid? Am I ER positive ? Should I be taking Aromasin? Which I am, by the way. My doctor said I was ER positive via the IHC staining. If you look at the oncotype results it does say positive either by Their test OR IHC.
    <br />So I did have chemo, am taking Aromasin , and hoping. It all makes me very grumpy.

  • AllieM
    AllieM Member Posts: 44
    edited March 2013

    Hi all,

    I'm a newby here so not sure if I'm in the right place. Has anyone here had an intermediate oncotype score and decided not to have chemo? Or know of anyone who has?    I have to decide tomorrow to have chemo or not and I've been going back and forth daily with my decision since the oncologist brought it up. My oncotype DX score was 27 (17% recurrence with tamoxifin). I was sure I wouldn't need chemo after BMX for 1.1 cm mass on right side with negative nodes, so I was thrown for a loop when he suggested chemo for 6 weeks and then AI (postmenopausal).  I have asked everyone I know what they would do and read everything I can find, and still can't come up with a decision I feel confident about. I already have digestive problems (reflux) and chronic low back pain. Anyway, I am in a hurry - gotta go to work, but would like anyone's input. Thanks!

  • pupmom
    pupmom Member Posts: 5,068
    edited March 2013

    Allie, you could go either way, but if it were me I would probably do the chemo. Do you how much your recurrence rate is reduced by chemo?

Categories